About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04032106

HPV Vaccine Intervention for Young Sexual Minority Men

This phase III trial studies how well the Outsmart HPV intervention works in increasing HPV vaccine initiation and completion among young individuals who report having a history of same-sex partners, ...

Lead sponsor: Ohio State University Comprehensive Cancer Center•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

National Cancer Institute (NCI)

PRIMARY OBJECTIVES: I. Determine the efficacy of the Outsmart HPV intervention on increasing HPV vaccine initiation and completion. II. Identify mediators that explain the relationship between study arm and HPV vaccine initiation and completion. III. Determine if intervention efficacy differs across key demographic and health-related characteristics of participants. OUTLINE: Participants are randomized to 1 of 3 groups. GROUP A: Participants receive standard information about HPV and HPV vaccine via a mobile-friendly website. GROUP B: Participants receive Outsmart HPV with unidirectional vaccine reminders (i.e. reminders that do not give participants the option to respond). GROUP C: Participants receive Outsmart HPV with interactive vaccine reminders (i.e. reminders that allow participants to respond). Participants in all study group are followed for 9 months.

Age

18 - 25 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Cisgender male
•Ages 18-25
•Sexual minority (reports ever having oral or anal sex with a male or being sexually attracted to males; or identifies as gay, bisexual, or queer)
•Lives in the United States (US)
•Has not received any doses of HPV vaccine
•Did not participate in the pilot study
•Read English
•Able to provide informed consent (inferred by completing the screener survey and consent form)

Related studies

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713 · Healthy Participants, Healthy Subjects, and more

RECRUITINGEARLY Phase 1

Single-tracer Multiparametric PET Imaging

NCT06014515 · Healthy Subjects, Cardiovascular Disease

RECRUITINGPhase 1

A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

NCT07181369 · Healthy Subjects, Cold Urticaria, and more

Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metabolic Regulation in Adults

NCT07364149 · Healthy, Healthy Participants, and more

RECRUITINGPhase 1

A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects

NCT07219940 · Healthy Subjects, Exosome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 14, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment1,227

Start dateOct 2019

Last updatedMar 14, 2025

Condition

Healthy Subject

Locations shown

University of Minnesota

Minneapolis, Minnesota

Ohio State University Comprehensive Cancer Center

Columbus, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 14, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions